ArticleAmerican journal of respiratory and critical care medicine2022
Impairment of the NKT-STAT1-CXCL9 Axis Contributes to Vessel Fibrosis in Pulmonary Hypertension Caused by Lung Fibrosis.
Abstract read
In one paragraph
Article in American journal of respiratory and critical care medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.
0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
8.1field-weighted citation impact, top 2% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
35 citing papers in PubMed, 55 citations in OpenAlex.
- LRRC8A deficiency in vascular smooth muscle cells promotes STAT1/Calcrl/Ramp1 signaling to decrease blood pressure.Acta pharmacologica Sinica · 2026Article
- Transcriptional landscape of pulmonary artery endothelium reveals subpopulation- and disease-specific remodeling signatures.Communications biology · 2026Article
- Clinical significance of radiological usual interstitial pneumonia pattern in primary Sjögren syndrome-associated interstitial lung disease.Frontiers in immunology · 2026Article
- Association of an inflammaging score based on IL-6, IL-10 and CXCL9, and frailty with long-term mortality in hospitalized older adults.Immunity & ageing : I & A · 2025Article
- Apatinib-Induced STAT1/NK axis activation augments PD-1 inhibitor efficacy in advanced Hepatocellular Carcinoma.Scientific reports · 2025Article
- Clinical Characteristics, Imaging Patterns and Management in Male and Female Patients with Primary Sjögren's Syndrome-associated Interstitial Lung Disease.Clinical rheumatology · 2025Article
- The Immune Microenvironment: New Therapeutic Implications in Organ Fibrosis.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Review
- Machine learning assisted immune profiling of COPD identifies a unique emphysema subtype independent of GOLD stage.iScience · 2025Article
- Signaling pathways and targeted therapy for pulmonary hypertension.Signal transduction and targeted therapy · 2025Review
- New insights into pulmonary arterial hypertension: interaction between PANoptosis and perivascular inflammatory responses.Apoptosis : an international journal on programmed cell death · 2025Review
- Transcriptional signatures of endothelial cells shape immune responses in cardiopulmonary health and disease.JCI insight · 2025Review
- Decoding the complexity: mechanistic insights into comorbidities in idiopathic pulmonary fibrosis.The European respiratory journal · 2025Review
- Unveiling the key mechanisms of FOLR2+ macrophage-mediated antitumor immunity in breast cancer using integrated single-cell RNA sequencing and bulk RNA sequencing.Breast cancer research : BCR · 2025Article
- SPP1hi macrophages, NKG7 T cells, CCL5hi fibroblasts, and IgM plasma cells are dominant features of necrobiosis.JCI insight · 2025Article
- Macrophage TRIM21 lactylation exacerbates infection-induced orchitis through enhancing STAT1-mediated CXCL9 and CXCL10 production.Frontiers in immunology · 2025Article
- Review
- Understanding Comorbidities of Respiratory Models as Novel Platforms for Drug Discovery.ACS pharmacology & translational science · 2024Review
- What Is on the Horizon for Treatments in Idiopathic Pulmonary Fibrosis?Journal of clinical medicine · 2024Review
- Pathology and pathobiology of pulmonary hypertension: current insights and future directions.The European respiratory journal · 2024Review
- Simultaneous Positron Emission Tomography and Molecular Magnetic Resonance Imaging of Cardiopulmonary Fibrosis in a Mouse Model of Left Ventricular Dysfunction.Journal of the American Heart Association · 2024Article
Corrections and comments
- Commented on by
- Commented on by
Authors and funding
18 authors at 4 institutions in 2 countries.
Katharina JandlLudwig Boltzmann Institute for Lung Vascular Research, Graz, Austria.
Leigh M MarshLudwig Boltzmann Institute for Lung Vascular Research, Graz, Austria.
Ayse Ceren MutganLudwig Boltzmann Institute for Lung Vascular Research, Graz, Austria.
Slaven CrnkovicLudwig Boltzmann Institute for Lung Vascular Research, Graz, Austria.
Francesco ValzanoLudwig Boltzmann Institute for Lung Vascular Research, Graz, Austria.
Diana ZabiniLudwig Boltzmann Institute for Lung Vascular Research, Graz, Austria.
Julia HoffmannLudwig Boltzmann Institute for Lung Vascular Research, Graz, Austria.
Vasile ForisLudwig Boltzmann Institute for Lung Vascular Research, Graz, Austria.
Elisabeth GschwandtnerDepartment of Surgery and.
Walter KlepetkoDepartment of Surgery and.
Helmut ProschDepartment of Biomedical Imaging and Image Guided Therapy, Medical University of Vienna, Vienna, Austria.
Holger FlickDivision of Pulmonology, Department of Internal Medicine, and.
Luka BrcicDiagnostic and Research Center for Molecular BioMedicine, Diagnostic & Research Institute of Pathology, Medical University of Graz, Graz, Austria.
Izidor KernCytology and Pathology Laboratory, University Clinic of Respiratory and Allergic Diseases Golnik, Golnik, Slovenia; and.
Akos HeinemannDivision of Pharmacology.
Horst OlschewskiLudwig Boltzmann Institute for Lung Vascular Research, Graz, Austria.ORCID 0000-0002-2834-7466
Gabor KovacsLudwig Boltzmann Institute for Lung Vascular Research, Graz, Austria.
Grazyna KwapiszewskaLudwig Boltzmann Institute for Lung Vascular Research, Graz, Austria.
Ludwig Boltzmann Institute for Lung Vascular Research · ATMedical University of Graz · ATMedical University of Vienna · ATUniversity Clinic of Pulmonary and Allergic Diseases Golnik · SI
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Hypertension, PulmonaryLung Diseases, InterstitialPulmonary FibrosisAnimalsChemokine CXCL9CollagenHumansInterleukin-15Leukocytes, MononuclearMiceNatural Killer T-CellsSTAT1 Transcription FactorChemokine CXCL9CollagenCXCL9 protein, humanInterleukin-15STAT1 protein, humanStat1 protein, mouseSTAT1 Transcription Factorimmunotherapyinterstitial lung diseasevascular fibrosisvascular remodeling
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.